Brett A. Sandercock's most recent trade in Resmed Inc. was a trade of 1,000 ResMed Common Stock done at an average price of $224.3 . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ResMed | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 224.31 per share. | 01 Apr 2026 | 1,000 | 83,495 (0%) | 0% | 224.3 | 224,310 | ResMed Common Stock |
| ResMed | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 257.03 per share. | 02 Feb 2026 | 1,000 | 85,495 (0%) | 0% | 257.0 | 257,030 | ResMed Common Stock |
| ResMed | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 241.75 per share. | 02 Jan 2026 | 1,000 | 86,495 (0%) | 0% | 241.8 | 241,750 | ResMed Common Stock |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Dec 2025 | 1,000 | 87,495 (0%) | 0% | 244.2 | 244,160 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 20 Nov 2025 | 2,710 | 88,495 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 03 Nov 2025 | 3,000 | 85,745 (0%) | 0% | 247.5 | 742,620 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 03 Nov 2025 | 2,000 | 88,745 (0%) | 0% | 101.6 | 203,280 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 03 Nov 2025 | 2,000 | 0 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Oct 2025 | 3,000 | 86,745 (0%) | 0% | 274.4 | 823,080 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Oct 2025 | 2,000 | 89,745 (0%) | 0% | 101.6 | 203,280 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Oct 2025 | 2,000 | 2,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 02 Sep 2025 | 3,000 | 87,745 (0%) | 0% | 270.8 | 812,310 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 02 Sep 2025 | 2,000 | 4,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 02 Sep 2025 | 2,000 | 90,745 (0%) | 0% | 101.6 | 203,280 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 15 Aug 2025 | 5,462 | 88,745 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Aug 2025 | 3,000 | 83,283 (0%) | 0% | 281.9 | 845,700 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Aug 2025 | 2,000 | 6,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Aug 2025 | 2,000 | 86,283 (0%) | 0% | 101.6 | 203,280 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Jul 2025 | 3,883 | 84,283 (0%) | 0% | 257.0 | 997,892 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Jul 2025 | 1,966 | 8,917 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Jul 2025 | 1,966 | 87,249 (0%) | 0% | 101.6 | 199,824 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Jul 2025 | 917 | 88,166 (0%) | 0% | 101.6 | 93,204 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 01 Jul 2025 | 917 | 8,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 02 Jun 2025 | 1,000 | 85,283 (0%) | 0% | 243.8 | 243,780 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 22 May 2025 | 3,644 | 86,283 (0%) | 0% | 244.6 | 891,286 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 08 Apr 2025 | 1,000 | 89,864 (0%) | 0% | 215.6 | 215,580 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Mar 2025 | 1,000 | 90,864 (0%) | 0% | 230.4 | 230,360 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Feb 2025 | 1,000 | 91,864 (0%) | 0% | 239.0 | 238,980 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 09 Dec 2024 | 1,000 | 93,864 (0%) | 0% | 244.2 | 244,230 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 08 Nov 2024 | 1,000 | 94,864 (0%) | 0% | 249 | 249,000 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 08 Oct 2024 | 1,000 | 95,812 (0%) | 0% | 233.5 | 233,470 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 09 Sep 2024 | 1,000 | 96,812 (0%) | 0% | 246.4 | 246,420 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 15 Aug 2024 | 7,915 | 96,971 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 15 Aug 2024 | 841 | 97,812 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 08 Aug 2024 | 1,000 | 89,056 (0%) | 0% | 212.2 | 212,160 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 08 Jul 2024 | 1,000 | 90,056 (0%) | 0% | 194.4 | 194,350 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Jun 2024 | 1,000 | 91,056 (0%) | 0% | 209.8 | 209,810 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 08 May 2024 | 13,000 | 92,056 (0%) | 0% | 211.4 | 2,747,810 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 08 May 2024 | 12,000 | 105,056 (0%) | 0% | 101.6 | 1,219,680 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 08 May 2024 | 12,000 | 10,883 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 27 Nov 2023 | 3,000 | 92,962 (0%) | 0% | 152.6 | 457,860 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 17 Aug 2023 | 4,972 | 95,915 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 May 2023 | 12,574 | 90,942 (0%) | 0% | 233.1 | 2,931,395 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 09 May 2023 | 3,426 | 103,516 (0%) | 0% | 232.0 | 795,000 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 17 Feb 2023 | 10,000 | 106,880 (0%) | 0% | 215.2 | 2,152,196 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 13 Feb 2023 | 4,000 | 116,880 (0%) | 0% | 215 | 860,000 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 23 Nov 2022 | 14,577 | 120,880 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 07 Nov 2022 | 4,000 | 106,303 (0%) | 0% | 212.0 | 848,068 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 18 Aug 2022 | 3,847 | 110,273 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Aug 2022 | 2,500 | 106,426 (0%) | 0% | 240.7 | 601,650 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Aug 2022 | 2,500 | 108,926 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Aug 2022 | 2,500 | 0 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 22 Jul 2022 | 7,500 | 106,426 (0%) | 0% | 235 | 1,762,500 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 22 Jul 2022 | 2,500 | 113,926 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 22 Jul 2022 | 2,500 | 108,926 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 22 Jul 2022 | 2,500 | 2,500 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 22 Jul 2022 | 2,500 | 5,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 22 Jul 2022 | 2,500 | 7,500 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 22 Jul 2022 | 2,500 | 111,426 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 11 Apr 2022 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 11 Apr 2022 | 2,500 | 10,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 11 Apr 2022 | 2,500 | 106,354 (0%) | 0% | 247 | 617,500 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Mar 2022 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Mar 2022 | 2,500 | 12,500 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Mar 2022 | 2,500 | 106,354 (0%) | 0% | 241.3 | 603,225 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Feb 2022 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Feb 2022 | 2,500 | 15,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Feb 2022 | 2,500 | 106,354 (0%) | 0% | 241.9 | 604,650 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Jan 2022 | 2,500 | 17,500 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Jan 2022 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Jan 2022 | 2,500 | 106,354 (0%) | 0% | 235 | 587,500 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Dec 2021 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Dec 2021 | 2,500 | 20,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Dec 2021 | 2,500 | 106,354 (0%) | 0% | 264.9 | 662,300 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 16 Nov 2021 | 20,360 | 105,193 (0%) | 0% | 254.8 | 5,187,932 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 16 Nov 2021 | 1,161 | 106,354 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Nov 2021 | 2,500 | 87,333 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Nov 2021 | 2,500 | 22,500 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Nov 2021 | 2,500 | 84,833 (0%) | 0% | 260.6 | 651,450 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 11 Oct 2021 | 5,000 | 84,786 (0%) | 0% | 253.4 | 1,266,850 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 11 Oct 2021 | 2,500 | 89,786 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 11 Oct 2021 | 2,500 | 25,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Sep 2021 | 5,000 | 87,286 (0%) | 0% | 297.3 | 1,486,650 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Sep 2021 | 2,500 | 27,500 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Sep 2021 | 2,500 | 92,286 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 20 Aug 2021 | 10,736 | 89,786 (0%) | 0% | 281.7 | 3,024,653 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 20 Aug 2021 | 5,543 | 30,000 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 20 Aug 2021 | 5,543 | 100,522 (0%) | 0% | 57.8 | 320,164 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 20 Aug 2021 | 5,193 | 35,543 | - | - | ResMed Common Stock Options | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 20 Aug 2021 | 5,193 | 94,979 (0%) | 0% | 57.8 | 299,948 | ResMed Common Stock | |
| ResMed | Brett A. Sandercock | Chief Financial Officer | 19 Aug 2021 | 4,784 | 89,786 (0%) | 0% | 0 | ResMed Common Stock | ||
| ResMed | Brett A. Sandercock | Chief Financial Officer | 10 Aug 2021 | 2,500 | 85,002 (0%) | 0% | 278.1 | 695,125 | ResMed Common Stock |